CLINICAL_TRIALS
research
· 2026-03-10
Clinical Trial Update: Kamuvudine-9 (K9) in Diabetic Macular Edema [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating Kamuvudine-9 (K9) for diabetic macular edema is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Bryan Strelow | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: RECRUITING